Charnwood Molecular will be taking part in a forthcoming trade mission to Denmark, alongside its strategic partners.

The mission will be heading to Denmark on the 25th March 2015 on a market visit supported by UKTI and hosted at the residence of the British Ambassador in Copenhagen.

The market visit, entitled: “The Changing Face of Pharmaceutical Discovery and Development – A Collaborative CRO Approach” will provide an opportunity for life science research companies across the Nordik region to meet and discuss how collaborative outsourcing can overcome the key scientific challenges within R&D.

Charnwood Molecular has been keen in developing the approach and has seized the opportunity to promote the collaborative approach to win new business.

Aimed at R&D scientists, project leaders and resource managers, the meeting will consist of opening presentations reflecting on current trends in outsourcing worldwide with particular reference to Scandinavia.

Representatives from all CROs will give an overview of how their services are applied to problem solving within the R&D pipeline. Further discussion is then planned to explore opportunities.

“We aim to capitalise on the collaborative approach that this trip gives and places us ideally to help Nordik companies looking for support with their research projects,” states Dr Robin Wilkes, Business Development Director – Medicinal Chemistry at Charnwood Molecular. “We are keen to work together with these companies that naturally complement our services and this is another vehicle to do so.”

The companies attending complement Charnwood Molecular in their drug discovery activities and process development. Aurelia BioScience covers compound screening to identify hit and lead molecules. XenoGesis are specialists in drug metabolism and pharmacokinetics (DMPK) testing. Reach Separations provides the analytical and chromatographic expertise, particularly for chiral compounds. Molecular Profiles provides pharmaceutical development services and clinical trial manufacturing for small molecules and can work from early phase development to late stage clinical manufacture. Biopta addresses the issue of translational relevance, proving data from tailored fresh human tissue assay systems; interfacing with the other groups by testing novel molecules for efficacy, absorption or safety in healthy and diseased tissue.

The market visit follows a successful two-day visit to Switzerland last year organised and supported by UKTI.

New Equipment 2015

Charnwood Molecular has again increased its capabilities with the acquisition of two new pieces of equipment – a new photochemical reactor and a new ozone generator.

Rayonet RMR-200 Photochemical Reactor:
Allowing reaction volumes up to 2L, the Rayonet reactor is a state of the art device, needing no eternal cooling. It is an intense, safe source of ultraviolet light at 254nm using 16 separate light sources.

Designed for the photolysis of hetercyclic compounds, ketones, halogen derivatives, olefins etc, the reactor opens up a whole new area of chemistry that Charnwood Molecular can offer its clients.

Triogen LAB2B Ozone generator:
The LAB2B ozone generator is a small air-cooled unit designed for bench use incorporating function indicators, feed gas flowmeter and variable output control. Operating on various feed gases such as dried air or oxygen the LAB2B is capable of producing concentrations up to 10% volume.

conferences  2015

We are in the process of arranging our forthcoming events and conference schedule for the coming year.

Our scientists intend to be present at the following one day events in the first half of 2015 and we’d be happy to meet there to discuss our outsourcing offering:

Event: RSC Nucleosides and Nucleotides symposium: synthetic and biological chemistry
Date: 17 April 2015
Venue: RSC, London

Event: Drug Discovery Chemistry
Date: 21-23 April 2015
Venue: San Diego, CA, USA

Event: 26th Symposium on Medicinal Chemistry in Eastern England
Date: 23 April 2015
Venue: Hatfield, Hertfordshire

Event: WPC – World Preclinical Congress
Date: 10-12 June 2015
Venue: Boston, MA, USA

Should you wish to arrange a meeting in advance at any of these events, please contact:

Robin Wilkes

blog newstory

We have recently launched a new blog on our site, which airs the views of one of our chemists, Phil Thorne MRSC C.Chem. Phil is a Senior Research Chemist at Charnwood and the blog gives him the opportunity to share issues of the day with like-minded or interested readers.

The blog will be updated regularly with pertinent stories on both drug discovery issues and the wider scientific environment. We hope you find both an interesting and informative read.

The blog can be read here:

mtsc oxford university
We have added a further event to our forthcoming conference schedule for the month of December.

We will now also be in attendance at the following event:

Event: The Future of Drug Discovery: Open Innovation
Date: 4 December, 2014
Venue: Medical Sciences Teaching Centre, University of Oxford

Should you wish to meet our representative at this event, please email:

In December, Charnwood representatives will be attending the following conferences.

Event: Recent Disclosures of Clinical Candidates
Date: 4 December, 2014
Venue: NHLI, Kensington, London

Event: 2nd Winter Process Chemistry Conference
Date: December 10-12, 2014
Venue: Manchester Conference Centre, Manchester, UK

Our representatives will be in attendance and available to meet any interested attendees or exhibitors.

Should you wish to organise a meeting in advance of the event, please email:


We look forward to seeing you there!


Charnwood Molecular are recruiting……

As part of an ongoing expansion to meet the rising demand for our services, we are looking to recruit a number of experienced synthetic and medicinal chemists to join our project teams.

For further information and to apply for a post, please click here:

Charnwood are in attendance at Medchem 2014, a one day conference on medicinal chemistry, which takes place on Friday, 21st November in Braine l’Alleud, Belgium.

The venue is the “Lloyd Conference” room at UCB Pharma in Braine-l’Alleud.

We would welcome the opportunity to meet with any interested parties who are in attendance at the event.

Please do not hesitate to get in touch, should you be going to the event and wish to discuss anything with Charnwood’s representatives.

Please email:

Dr Sylvain Blanc – email:

We look forward to seeing you there!

conference1Charnwood Molecular is venturing into the Brazilian market for the first time….

The 7th Brazilian Symposium on Medicinal Chemistry (BrazMedChem2014) will be held at the Campos do Jordao Convention Center, in Campos do Jordao (Sao Paulo State) Brazil, from November 9 to 12, 2014.

The event will allow international scientists will get together in Campos do Jordao to discuss the intricacies of the drug discovery process.

Our representatives will be in attendance and available to meet any interested parties from companies looking at outsourced chemistry services.

Should you wish to organise a short meeting in advance of the event, please email:

Dr Sylvain Blanc – email:

We look forward to seeing you there!

charnwood updated conferences
Charnwood has added to its forthcoming conference schedule, and in the near future it will be in attendance at the following events, conferences and exhibitions.

If you would like further information on our participation in any of these, or would like to arrange to meet one of our representatives at any of the venues, please contact us via email at:

Event: 7th Brazilian Symposium on Medicinal Chemistry (BrazMedChem2014)
Date: November 9th to 12th 2014
Venue: Campos do Jordao (Sao Paulo State), Brazil

Event: New Vistas in GPCR Research: the Dawn of an Exciting Drug Discovery Era?
Date: November 21st 2014
Venue: Braine-L’Alleud, Belgium

Event: CNS Drug Discovery
Date: November 26th 2014
Venue: Takeda, Cambridge, UK